Experience in using a vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia

Manukhina E.I., Ispas A.A.

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
Objective. To present the authors’ own experience in using a Pregnotone vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia.
Subjects and methods. Examinations were made in 135 reproductive-aged women with functional hyperprolactinemia and menstrual irregularities before and after a 3-month Pregnotone treatment cycle.
Results. After a month of Pregnotone intake, 80/135 (59.2%) followed up patients reported their general health improvements (in mood and sleep); the menstrual cycle was restored and became regular in 26/135 (19.2%) cases. After completing a full (3-month) Pregnotone treatment cycle, there was a considerable health improvement in 115/135 (85.2%) cases; the menstrual cycle was noted to be restored in 110/135 (81.5%) patients.
Conclusion. The balanced vitamin and mineral supplement Pregnotone has a positive effect on a woman’ general well-being (better mood and better sleep) and can be used to treat menstrual irregularities in patients with functional hyperprolactinemia. A substantial effect of Pregnotone should be expected after its 3-month treatment cycle.

Keywords

functional hyperprolactinemia
menstrual irregularities
Pregnotone

References

  1. Громова О.А., Торшин И.Ю. Витамины и микронутриенты: между Сциллой и Харибдой. МЦНМО, 2013; 869. [Gromova O.A., Torshin I.Ju. Vitaminy i mikronutrienty: mezhdu Scilloj i Haribdoj. MCNMO, 2013; 869. (in Russian)].
  2. Иловайская И.А. Диагностика и лечение гиперпролактинемии: клинические рекомендации Международного эндокринологического общества и взгляд российских экспертов. Фарматека: Акушерство и гинекология. 2012, 1: 2–7. [Ilovayskaya I.A. Diagnostika i lecheniye giperprolaktinemii: klinicheskiye rekomendatsii Mezhdunarodnogo endokrinologicheskogo ob-shchestva i vzglyad rossiyskikh ekspertov. Farmateka: Akusherstvo i ginekologiya. 2012; 1: 2–7. (in Russian)].
  3. Famini P., Maya M.M., Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metabol. 2011; 96: 1633–41. doi: 10.1210/jc.2011-0168
  4. Дедов И.И., Мельниченко Г.А, Романцова Т.И. Эндокринология. Национальное руководство. М.: ГЭОТАР-Медиа, 2015: 589–94. [Dedov I.I., Melnichenko G.A., Romantsova T.I. Endocrinilogy: National guide. M.: GEOTAR-Media. 2015; 589–94. (In Russ.)].
  5. Дедов И.И., ред. Клиническая нейроэндокринология. М. 2011: 113–8. [Dedov I.I., red. Klinicheskaya neyroendokrinologiya. M. 2011: 113–8. (in Russian)].
  6. Melmed S., Casanueva F.F., Hoffman A.R. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(2): 273–88. doi: 10.1210/jc.2010-1692.
  7. Подзолкова Н.М., Глазкова О.Л. Симптом, синдром, диагноз. Дифференциальная диагностика в гинекологии. [Электронный ресурс]. М.: ГЭОТАР-Медиа, 2014. 736 с. Режим доступа: https://www.rosmedlib.ru/book/ISBN9785970426937.html. [Podzolkova N.M., Glazkova O.L. Symptom, syndrome, diagnosis. Differential diagnosis in gynecology. [Electronic resource]. M.: GEOTAR-Media, 2014. 736 p. available in: https://www.rosmedlib.ru/book/ISBN9785970426937.html (In Russan)]
  8. Ларина А.А., Григорян О.Р., Андреева Е.Н., Дзеранова Л.К. Гиперпролактинемия и беременность. Проблемы репродукции. 2013; 3: 13–17. [Larina A.A., Grigorian O.R., Andreeva E.N., Dzeranova L.K. The hyperprolactinemia and pregnancy (a review). Russian Journal of Human Reproduction = Problemy reproduktsii. 2013; (3): 13–17. (In Russan)]
  9. Герасимович Е.М. Гормональные и метаболические нарушения при использовании препаратов заместительной гормональной терапии и препаратов растительного происхождения. Мед. новости. 2008; 1: 98–102. [Gerasimovich E.M. Gormonalnye i metabolicheskie narusheniya pri ispolzovanii preparatov zamestitelnoy gormonalnoy terapii i preparatov rastitelnogo proishozhdeniya. Med. novosti. 2008; 1: 98–102. (in Russian)]
  10. Вуттке В., Ярри Г., Зайдлова-Вуттке Д. Терапевтические возможности экстрактов из Аврамова дерева (Vitex Agnus castus) в гинекологической практике. Проблемы репродукции. 2009; 4: 53–7. [Vuttke, V., Yarri G., Zaydlova-Vuttke D. Terapevticheskie vozmozhnosti ekstraktov iz Avramova dereva (VitexAgnuscastus) v ginekologicheskoy praktike. Problemi reprodukcii. 2009; 4: 53–7. (in Russian)].
  11. Wu G., Bazer F.W., Satterfield M.C., Li X., Wang X., Johnson G.A., Burghardt R.C., Dai Z., Wang J., Wu Z. Impacts of arginine nutrition on embryonic and fetal development in mammals. Amino Acids. 2013; 45(2): 241–56. https://doi.org/10.1007/s00726-013-1515-z
  12. Babey M., Sahli R., Vajtai I., Andres R.H., Seiler R.W. Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonist. Pituitary. 2011; 14: 222–30. doi: 10.1007/s11102-010-0283-y.

Received 05.02.2020

Accepted 07.02.2020

About the Authors

Ekaterina I. Manukhina, MD, professor, FSFEI HE Moscow A. I. Evdokimov University of Medicine and Dentistry. Е-mail: katemanu@mail.ru
Address: 127473, Russia, Moscow, Delegatskaya str., bld. 20.
Anastasia A. Ispas, obstetrician-gynecologist of state budgetary healthcare institution, city clinical hospital named after E.O. Mukhin. Е-mail: ispasanastasia@mail.ru
Address: 127473, Russia, Moscow, Delegatskaya str., bld. 20.

For citation: Manukhina E.I., Ispas A.A. Experience in using a vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia.
Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2020; 2: 169-173. (In Russian).
https://dx.doi.org/10.18565/aig.2020.2.169-173

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.